Kate Lawrence

Kate Lawrence is an accomplished professional in the field of regulatory affairs with extensive experience in virology and liver disease. Currently serving as Associate Director at Gilead Sciences since September 2019, Kate was previously a Senior Manager and a Regulatory Affairs Manager, contributing to pivotal projects within these specialties. Prior roles include Senior Regulatory Affairs Associate at BeiGene, where Kate led the development of global clinical trial applications for oncology studies and provided strategic assessments to senior leadership. Previously at Achaogen, Kate managed complex regulatory projects and facilitated multiple FDA interactions. Earlier experience at Genentech involved supporting hematology program submissions and regulatory research. Kate holds a Ph.D. in Cell/Cellular and Molecular Biology from the University of California, Davis, and a Bachelor's Degree in Biology from the same institution. Additionally, extensive research background includes postdoctoral fellowship at the University of California, San Francisco.